FBP1 and cancer: Fructose-1,6-bisphosphatase (FBP1), a gluconeogenesis enzyme that is often downregulated in cancer, can also directly bind to the WW domain of IQGAP1 and therefore inhibit IQGAP1-mediated ERK activation [127].